Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment

Research output: Contribution to journalComment/debateResearchpeer-review

Documents

  • Fulltext

    Final published version, 552 KB, PDF document

  • the PROUD-PV Study Group
Original languageEnglish
JournalLeukemia
Volume37
Issue number10
Pages (from-to)2129-2132
Number of pages4
ISSN0887-6924
DOIs
Publication statusPublished - 2023

ID: 370578149